Omeprazole (OME) exhibits low stability to light, heat and humidity. In stress conditions OME stability should improve under inclusion complex form with hydroxypropyl-β-cyclodextrin (HPβCD). Stability of OME, its physical mixture (PM) with HPβCD and OME:HPβCD inclusion complex was assessed during 60 days. The inclusion complexes were prepared by kneading and freezedrying techniques and characterized by differential scanning calorimetry (DSC) and Fourier transform infrared spectroscopy (FTIR). A molecular modelling was also held to predict the most probable tridimensional conformation of inclusion complex OME:HPβCD. The inhibitory activity of free and complexed OME on selected enzymes, namely, papain (protease model of the proton pump) and acetylcholinesterase (enzyme present in cholinergic neurons and also involved in Alzheimer's disease) was compared. The results obtained show that HPβCD do not protect against OME degradation, in any prepared powder, in the presence of light, heat and humidity. This may indicate that the reactive group of OME is not included in the HPβCD cavity. This fact is supported by molecular modelling data, which demonstrated that 2-pyridylmethyl group of OME is not included into the cyclodextrin cavity. In relation to enzymatic assays it was observed that free OME and OME in the binary systems showed identical inhibitory activity on papain and acethylcolinesterase, concluding that HPβCD do not affect OME activity on these two enzymes.
Introduction
Omeprazole (OME), which belongs to the family of the gastric proton pump H + /K + -solution, its stability is dependent on pH; in acidic and neutral conditions greater stability in alkaline medi humidity [2] [3] [4] . Cyclodextrins (CDs) constitute a new class of pharmaceutical excipients chemical and biological undesirable properties non-covalent inclusion complexes with from inclusion complexes include: increase of solubility of insoluble drugs; stabilization against oxidation, hydrolysis and photolysis reactions; [6] . Hydroxypropyl-β-cyclodextrin (HP pharmaceutical formulation due to its high complexing ability [7, 8] . Moreover, Loftsson with HPβCD, in aqueous solution, reporting knowing that the solubility of OME was increased, t not, in the form of solid inclusion complexes, the -light, heat and humidity -so less degradation would conditions (light, heat, humidity). enzymes (papain and acetylcholinesterase complexes prepared, was evaluated by determination of drug concentration that inhibited 50% of the enzyme activity (IC 50 ). Papain is the enzyme normally chosen as an experimental model of enzyme kinetics of H + /K + -ATPase due to its easily accessible. Both enzymes cysteine proteases and, therefore, its catalytic mechanism is identical is an enzyme present in cholinergic neurons and in the control of nerve impulses. Its function is to catalyze the hydrolysis of the neurotransmitter acetylcholine to originate choline and the treatment of central nervous system degenerative diseases, particularly Alzheimer's disease, which consists on the replacement of ace therefore a great improvement of the patients' life quality [13] . As the OME has the ability to cross the brain blood barrier [14] it was also intended to study the action of the drug on this enzyme in order to assess its efficiency as an AChE inhibitor. which belongs to the family of substituted benzimidazoles (Fig. 1) , -ATPase [1] but presents physical and chemical instability. solution, its stability is dependent on pH; in acidic and neutral conditions it is rapidly degraded, showing greater stability in alkaline medium. In the solid state, the OME is degraded in presence of heat, light and Cyclodextrins (CDs) constitute a new class of pharmaceutical excipients used to change undesirable properties of certain drugs. Due to its lipophilic cavity, CDs forms complexes with poorly water-solube drugs [5] . The possible benefits obtained include: increase of solubility of insoluble drugs; stabilization against ysis and photolysis reactions; reduction or elimination of unpleasant effects and others cyclodextrin (HPβCD) is a β-cyclodextrin derivative with a great interest for armaceutical formulation due to its higher solubility in aqueous solutions; very low Moreover, Loftsson et al. [9] published a study of the complexation of OME CD, in aqueous solution, reporting a solubility improvement of the drug (Kc 69 M knowing that the solubility of OME was increased, the aim of this study was to investigate inclusion complexes, the OME would be more protected against so less degradation would be protected agains degradation under stress conditions (light, heat, humidity). The influence of HPβCD on the biological activity of OME on certain acetylcholinesterase), the inhibitory activity of free OME and OME of complexes prepared, was evaluated by determination of drug concentration that inhibited 50% of the Papain is the enzyme normally chosen as an experimental model of enzyme due to its easily accessible. Both enzymes (papain and cysteine proteases and, therefore, its catalytic mechanism is identical [10] . Acetylcholinesterase (AChE) is an enzyme present in cholinergic neurons and in the neuromuscular junctions that plays a key role on the control of nerve impulses. Its function is to catalyze the hydrolysis of the neurotransmitter to originate choline and acetate [11, 12] . The use of AChE inhibitors is a recent approach on the treatment of central nervous system degenerative diseases, particularly Alzheimer's disease, which consists on the replacement of acetylcholine by decreasing the degradation of the neurotransmitter, and is a great improvement of the patients' life quality [13] . As the OME has the ability to cross the also intended to study the action of the drug on this enzyme in order to assess its efficiency as an AChE inhibitor. degradation under stress n the biological activity of OME on certain OME of the inclusion complexes prepared, was evaluated by determination of drug concentration that inhibited 50% of the Papain is the enzyme normally chosen as an experimental model of enzyme (papain and H + /K + -ATPase) are Acetylcholinesterase (AChE) the neuromuscular junctions that plays a key role on the control of nerve impulses. Its function is to catalyze the hydrolysis of the neurotransmitter inhibitors is a recent approach on the treatment of central nervous system degenerative diseases, particularly Alzheimer's disease, which tylcholine by decreasing the degradation of the neurotransmitter, and is a great improvement of the patients' life quality [13] . As the OME has the ability to cross the also intended to study the action of the drug on this enzyme in order to kindly donated by MEDINFAR and by .8 U/mg protein; extracted from electric eel 349 U/mg solid, 411 U/mg protein; BAPA); acetylthiocholine iodide (AChI); 5,5'-dithiobis [2- Grade (MeOH); 4-(2-Sodium acetate from
Methods

Physical mixtures (PM)
The physical mixtures were prepared by mixing OME and HPβCD in 1:1 M molar (Fisher-Kendall Scientific Co., 12-811, USA) for 10 minutes.
Kneading (KN)
HPβCD (1.6210 g) was wetted by a basic aqueous solution (pH 10.3) (≈ 50% w/w) in a ceramic mortar and then the required amount of OME (0.4040 g) was slowly added (1:1 M ratio) and kneaded for 30 min until a slurry was obtained.
Freeze-drying (FD)
HPβCD (0.8103 g) was dissolved in a basic aqueous solution (pH 10.3) and then the required amount of OME (0.2017 g) was added (1:1 M ratio) under stirring for 24 h. Furthermore, the resultant solution was frozen in liquid nitrogen and was lyophilized (Christ Alpha 1-4 freezedryer, B. Braun Biotech International, Germany).
Differential scanning calorimetry (DSC)
The thermal behaviour of the different powders were performed by DSC (TC 11, TA Processor, Mettler, Germany) using 4 mg samples in closed aluminum pans at a heating rate of 10 ⁰C/min in 30 ⁰C -300 ⁰C.
Infrared spectroscopy (IR)
Fourier transform-infrared spectroscopy (FT-IR) Infrared spectra were performed on a spectrophotometer (Nicolet spectrophotometer, model Impact 400, USA) using the KBr disk method and scanned from 4000 to 400 cm -1 .
Molecular simulation
The MOE program was used to construct the OME and HPβCD molecules. The HPβCD molecule was obtained from βCD structure, by adding the substitution hydroxypropyl groups. allowed (hydroxypropyl groups). The geometries of the HPβCD and OME molecules were optimized with a semi-empirical quantum method AM1 [15] using the program Gaussian03 (www.gaussian.com). Subsequently held the inclusion of the molecule of OME (previously optimized) in the cavity of HPβCD, previously constructed, and was performed a calculation of molecular docking in order to study the conformational space of the CD and get the most favourable conformation of the complex.
Stability Studies
Stability studies of free OME and PM, KN and FD powder samples were carried out in glass bottles sealed with rubber stopper and parafilm, in three different environmental conditions, 24 h per day (during 60 days): a) actinic light at to room temperature and humidity; b) 40 °C and 75% relative humidity (Vötsch, Industrietechnick, VC 2033); c) 4 ºC in dark.
To assess the degradation of free OME (pure) and complexed OME (PM, KN and FD) aliquots were analyzed at 28 th and 60 th days by HPLC at a concentration of 20 µg/mL (dissolved in MeOH). As reference, samples were analyzed by HPLC before the start of this test (time 0 days).
HPLC
The apparatus of HPLC (Finnigan TM Surveyor ® Plus Modular LC System) was equipped with a column Purospher ® STAR RP-18 (Merck) with a UV detector set at 305 nm and the Xcalibur software. The following analytical conditions were used: injection volume of 25 µL, flow 1.0 mL/min and mobile phase: methanol/ammonia-water (60/40, v/v) pH 8.4. The running time was 20 min.
Kinetic experiments were performed for the enzyme papain and AChE, which were followed by UV-Vis spectroscopy in the presence and absence of OME and binary mixtures (PM, KN and FD). The control assay for each enzymatic reaction, corresponded, then, the absence of OME or binary mixture in the reaction medium and was considered 100% activity.
eq. 1
where enzim. rate sample is the enzymatic rate, in absorbance per minute, of the reaction containing OME or binary mixture and enzim. rate control is the enzymatic rate, in absorbance per minute, of the control reaction (absence of OME).
Papain
The enzymatic activity of papain was quantified by adapting the method described by Zhao et al. [16] . Papain solution (0.2 mg/mL) in sodium acetate buffer 50 mM pH 4.8 (2.5 mM EDTA e 7.5 mM DTT) was prepared in order to create an acidic environment similar to the parietal cells in the stomach, at the proton pump. The papain solution prepared was activated by DTT for 2 h at room temperature. The L-BAPA (30 mM in DMSO) was the substrate for papain and was followed by the formation of product 4-nitroaniline at 410 nm. The absorbance at 410 nm was read at intervals of 1 min for 10 min. The graph of absorbance (Abs) versus time (min) was plotted and the the rate of reaction was obtained from the equation:
where y corresponds to the absorbance, m to the rate of reaction and x to the time. The OME concentrations were varied from 0.109 to 0.579 mM in order to determine the concentration that inhibits 50% of enzyme activity (IC 50 ). We used the concentration of OME who originated the IC 50 in the sample free of OME for tests with binary mixtures and with free HPβCD. The assays were performed in triplicate.
Acetylcholinesterase (AChE)
The enzymatic activity of AChE was measured by adapting the method described by Falé et al. [17] . The substrate was acetylthiocholine iodide (AChI, 1 mM in distilled water).The product formed reacts with DTNB (3 mM in HEPES buffer 50 mM pH 8 with 50 mM NaCl and 20 mM MgCl 2 .6H 2 O), producing a colored compound, followed by reaction at 405 nm. The absorbance at 405 nm was read at intervals of 1 min for 5 min. The rate of the reaction was obtained by the same method that was used in papain. The concentrations of free OME and OME in binary systems were varied from 0.015 mM to 0.434 mM in order to determine the concentration that inhibits 50% of enzyme activity (IC 50 ). Kinetic assays of AChE with free HPβCD with two different concentrations 0.506 and 0.203 mM were also performed. The assays were performed in triplicate.
Statistical analysis
The significance of the IC 50 values obtained on the inhibitory activity tests of OME and binary mixtures on AChE was tested by ANOVA (Analysis of Variance) F-Snedecor distribution with a range of 95%. 
Results and Discussion
Differential scanning calorimetry (DSC)
The DSC thermogram of OME shows one characteristic sharp endothermic peak at around 156 ⁰C, indicating the melting point of the drug, followed by an exothermic effect at 173 °C, relative to its thermal decomposition (Fig. 2a) . The thermogram corresponding to HPβCD (Fig. 2b) shows a broad endothermic effect between 60 and 120 °C, attributed to the loss of water molecules in the cavity of the CD [18] . For the PM, both the characteristic peaks of the drug (melting peak) as the effect of HPβCD endothermic (dehydration) are present (Fig. 2c) , without deviation of the OME melting point, demonstrating absence of inclusion complexes. The thermogram of the sample KN (Fig. 2d) shows an endothermic peak, corresponding to the OME melting point, but with low intensity and relatively broader than the pure drug, also suffering from a shift to a lower temperature. This indicates that some interaction between OME and HPβCD occurred. The disappearance of the OME melting point peak in FD sample suggests an incorporation of the drug in the HPβCD cavity (Fig. 2e) .
Fig. 2 DSC thermograms of (a) OME, (b) HPβCD, (c) PM, (d) KN and (e) FD.
Infrared spectroscopy (IR)
The FTIR spectrum of OME (Fig. 3a) shows two characteristic bands at 1625.99 cm -1 , corresponding to stretching link vibration (C=C-N and S-C=N), and at 1203.31 cm -1 relative to the Ar-C-OCH3 vibration accompanied by resonance band at 1075 cm -1 (Fig. 3b) [4] . These two bands were used to analyze the interaction between OME and HPβCD. None of the binary mixtures presented the formation of new bands, indicating that no covalent bond was established in the complexes formed [19] . The characteristic bands of OME and HPβCD are present on the IR spectrum of PM, indicating that there was no interaction between the CD cavity and the groups responsible for the relevant IR absorption (Fig.  3c) . Identical result was observed for the KN sample (Fig. 3d) , although the band at 1203.31 cm -1 have less intensity than on the PM, reinforcing thus the idea of having partial interaction between the OME and CDs molecules, as mentioned above for the results obtained by DSC. In FD sample it can be observed that the OME absorption band at 1625.99 cm -1 has disappeared, appearing a band at 1647.81 cm -1 (Fig. 3e) , which is characteristic of HPβCD and corresponds to the elongation of the H-O-H bonds [20] . The intensity of the band at 1203.31 cm -1 is also significantly decreased. These results suggest that restrictions on the vibration of C=C-N, S-C=N and Ar-C-OCH 3 bonds due to its inclusion within the cavity of the CD probably occured.
Fig. 3 IR spectra of (a) OME, (b) HP
Molecular simulation
The most probable tridimensional conformation by molecular simulation (Fig. 4) . In the simulation model it is possible HPβCD cavity while the 2-pyridylmethyl complexation of -68,22 kJ/mol.
Fig. 4 Molecular docking of OME with HP
Stability Studies
Stability of both pure and complexed OME was evaluated under distinct environmental conditions such as light, heat and humidity. ost probable tridimensional conformation of inclusion complex OME:HPβCD . the simulation model it is possible to observe that the benzimidazole ring of OME is included into the pyridylmethyl group is outside the HPβCD cavity, featuring an energy of docking of OME with HPβCD molecule.
Stability of both pure and complexed OME was evaluated under distinct environmental conditions such CD could be observed of OME is included into the , featuring an energy of Stability of both pure and complexed OME was evaluated under distinct environmental conditions such At time 0 days, all samples (free OME, PM, KN an chromatograms it was found that different samples had no degradation products with the appearance of a well-defined peak, relative to OME Table 1 presents the results obtained for the degradation of OME in the various samples (free OME, PM, KN and FD) when exposed to different environmental physical aspect. On Table 1 it can be seen that actinic light of OME. It is also possible to conclude that OME under inclusion complex is OME in presence of actinic light and 40 ºC with 75% RH. HPβCD did not increase drug stability to light, heat and humidity, instead led to an increase in its rate of decomposition. This can be attributed to the different modes of inclusion for the same molecule; accelerated, retarded or remain the same remain outside the cavity of the HP accelerate the degradation of the drug through a reaction between 2 groups. There was also a change in the colo binary systems (Fig. 6 ), which suggests a relationship between the degradation degree and the colo the samples. Thus, it seems not to be advantageous to p protection despite this CD significantly increase the solubility of the drug At time 0 days, all samples (free OME, PM, KN and FD) were analyzed by HPLC. By the chromatograms it was found that different samples had no degradation products with the appearance of a OME in each sample, with retention time between 7.7 and 7.8 min (Fig. HPLC chromatograms of OME in the different samples (PM, KN, FD) at 0 days. Table 1 presents the results obtained for the degradation of OME in the various samples (free OME, PM, KN and FD) when exposed to different environmental conditions for 60 days and the Fig. actinic light is the environmental condition which cause . It is also possible to conclude that OME under inclusion complex is more degr OME in presence of actinic light and 40 ºC with 75% RH. Unlike desired, complexation of OME with CD did not increase drug stability to light, heat and humidity, instead led to an increase in its rate of This can be attributed to the CD used (HPβCD). Different types of CD may lead to inclusion for the same molecule; depending on CD, the degradation of the drug can be accelerated, retarded or remain the same [21] . The fact of 2-pyridylmethyl group from OME might remain outside the cavity of the HPβCD, as shown by supporting data from molecular simulation, may accelerate the degradation of the drug through a reaction between 2-pyridymethyl group and There was also a change in the colour of the different samples over the 60 days, m ), which suggests a relationship between the degradation degree and the colo it seems not to be advantageous to prepare inclusion complexes OME:HPβCD despite this CD significantly increase the solubility of the drug [9] .
) of free OME and OME present on different binary mixtures ( KN and the freeze-drying -FD methods) at different environmental conditions over 40 ºC, 75% humidity OME:HPβCD Pure OME OME:HPβCD Pure OME By the analysis of chromatograms it was found that different samples had no degradation products with the appearance of a time between 7.7 and 7.8 min (Fig. 5 ).
HPLC chromatograms of OME in the different samples (PM, KN, FD) at 0 days. Table 1 presents the results obtained for the degradation of OME in the various samples (free OME, PM, and the Fig. 4 shows its environmental condition which causes more degradation more degradable than pure Unlike desired, complexation of OME with CD did not increase drug stability to light, heat and humidity, instead led to an increase in its rate of Different types of CD may lead to depending on CD, the degradation of the drug can be thyl group from OME might CD, as shown by supporting data from molecular simulation, may pyridymethyl group and CD hydroxyl r of the different samples over the 60 days, more clearly in ), which suggests a relationship between the degradation degree and the colour of 
Enzymatic Studies
Biological activity of pure OME and OME as inclusion complex papain and AChE.
Papain
The IC 50 value obtained for the pure OME was 0 of the papain was obtained for the samples PM, KN and FD (Fig. activity of OME is not affected even in the presence of HP group of the drug, responsible for binding to the enzyme and, consequently, outside the CD cavity, enabling the reactio IC 50 . An enzymatic assay of papain with free HP that the enzyme activity is equal to the control assay. with the activity of papain, and therefore, as expected, it various binary mixtures. Similar results were reported by Gubica TMβCD ((2,3,6-tri-O-methyl)-β-lyase with the substrate L-tryptophan Fig. 7 Papain activity (%) in presence of pure and complexed OME. All samples had an OME concentration of 0.425 mM (n = 3).
Inclusion complexes (freeze-drying)
Pure OME 0 days
Physical aspect of pure OME and FD sample.
activity of pure OME and OME as inclusion complex was assessed by enzymatic assays using value obtained for the pure OME was 0.425 mM. At this OME concentration the same inhibition was obtained for the samples PM, KN and FD (Fig. 7) , concluding that the inhibitory activity of OME is not affected even in the presence of HPβCD. This could mean that the functional group of the drug, responsible for binding to the enzyme and, consequently, its inhibition enabling the reaction with papain and giving therefore rise to the same value of zymatic assay of papain with free HPβCD (without OME) was also carried being observed that the enzyme activity is equal to the control assay. It was then concluded that this CD does not interfere , and therefore, as expected, it is obtained similar enzyme activities between the Similar results were reported by Gubica et al. [22] , where the presence of -cyclodextrin) did not affect the enzymatic reaction of tryptophan tryptophan.
Papain activity (%) in presence of pure and complexed OME. All samples had an OME concentration of 0.425 mM (n = 3).
Actinic light 40 ºC, 75% humidity 4 ºC in dark 60 days ymatic assays using concentration the same inhibition concluding that the inhibitory This could mean that the functional inhibition, shall remain giving therefore rise to the same value of was also carried being observed concluded that this CD does not interfere obtained similar enzyme activities between the , where the presence of cyclodextrin) did not affect the enzymatic reaction of tryptophan indolePapain activity (%) in presence of pure and complexed OME. All samples had an OME
Acetylcholinesterase
The inhibitory activity of OME on acetylcholinesterase had not yet been determined in any published study. OME concentrations were varied from 0.015 to 0.434 mM in order to determine the concentration that inhibits 50% of enzyme activity (IC50). The IC50 value obtained for the pure OME was 0.224 ± 0.016 mM. This IC50 value differs from the IC50 of galantamine (1.07 ± 0.18 lM) [23] , an AChE inhibitor drug used to treat Alzheimer's disease [24] . However, the OME has a higher capacity of inhibit AChE compared to some natural compounds, particularly the monoterpenes, the major components of essential oils extracted from plants, flowers and fruits. 1.8-cineole and α-pinene are the most active monoterpenes with IC 50 values of 0.670 mM and 0.630 mM, respectively. The difference in the inhibitory effect of the various compounds in relation to AChE is related to the enzyme binding site, which may occur directly in the active site or in peripheral binding site or both sites [25] . The OME is therefore a substance with a promising structure that could be tested as a lead molecule for the development of new compounds that are more effective in the inhibition of AChE. To infer whether HPβCD affects the inhibitory effect of OME on AChE activity, IC 50 values of OME in the different binary systems (PM, KN and FD) were determined. The IC 50 values were 0.255 ± 0.011 mM for PM, 0.216 ± 0.048 mM for KN and 0.279 ± 0.004 mM for FD (Fig. 8) . The IC 50 values are similar for the OME in the different binary systems and free OME (pure) as was proved through statistical analysis (ANOVA, F-test for a probability of P = 0.05), that these values are not significantly different (F (3.78) <F crit (4.07)). This indicates that even when the OME is complexed with HPβCD, the functional group of the drug responsible for binding to the enzyme and, consequently, inhibition of the same, shall remain outside the cavity of the CD, allowing the reaction with AChE, giving therefore rise to the identical value of IC 50 between free and complexed OME, as was the case with papain. An enzymatic assay of AChE with free HPβCD (without OME) was also carried out observing that the enzyme activity is equal to the control assay. Thus, it seems that, as in the assay with papain, the CD used does not affect the activity of AChE. 
Conclusion
The methods used to characterize the prepared inclusion complexes showed that there was interaction of the OME with the HPβCD cavity. However HPβCD didn´t protect against OME degradation in the presence of light, heat and humidity, indicating that the reactive group of OME was not probably included into the CD cavity, as evidence by the data from molecular simulation. Enzymatic assays showed that free OME and OME in binary systems presented identical inhibitory activity on papain and acethycolinesterase, concluding that HPβCD didn´t affect OME activity on both enzymes. Moreover free HPβCD didn´t affect neither papain nor acetylcholinesterase activity.
